People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, LLC | — | Pharma | Series A | $12.8M | $396.9M | 2017 |
Lara Sullivan, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lara Sullivan, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Stephen Squinto | 1 | 8 |
| Daniel Lynch | 1 | 7 |
| Deval Patrick | 1 | 4 |
| Jeff Schwartz | 1 | 4 |
| Peter Keen | 1 | 2 |
| Freda Lewis-Hall, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.